| 1 | Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals | Coautor: Candelaria M., Duenas-Gonzalez A., Gonzalez-Fierro A., Bornstein-Quevedo L., et al. | 2024 | EXPERT REVIEW OF ANTICANCER THERAPY | WoS-id: 001265746600001
Scopus-id: 2-s2.0-85197804654
| 3 | 3 |
| 2 | Transformation of Follicular Lymphoma into Composite Lymphoma: A Case Report and Literature Review | Coautor: Candelaria, M, Avilés-Salas, A, Peña-Carvajalino, LF, Heredia-Jara, AN, et al. | 2024 | REVISTA MEDICA DE CHILE | WoS-id: 001334514600010
Scopus-id: 2-s2.0-85207350932
| 0 | 0 |
| 3 | Linfoma de células T/NK primario de testículo. Caso clínico y revisión de la literatura | Coautor: Candelaria M., Avilés-Salas A., Heredia-Jara A.N., Peña-Carvajalino L.F., et al. | 2023 | REVISTA MEDICA DE CHILE | WoS-id: 001163807400014
Scopus-id: 2-s2.0-85183729776
| 0 | 0 |
| 4 | Data presentation of results from randomized cancer clinical trials. The case for trials in advanced cervical cancer. A critical appraisal. | Coautor: Candelaria M., Duenas Gonzalez A., Coronel J., Cabrera-Galeana P., et al. | 2023 | F1000 Research | Scopus-id: 2-s2.0-85152933255
| 0 | 0 |
| 5 | Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) | Coautor: Candelaria, Myrna, Villela Martinez, Luis Mario, Beltran, Brady E., Torres Viera, Marialejandra Alejandra, et al. | 2022 | Blood | WoS-id: 000893223206321
| 0 | 0 |
| 6 | IBCL-490 POD24 and Serous Effusion Involvement Impact on Overall Survival in Follicular Lymphoma Attended at the National Cancer Institute in Mexico: A Survey of 370 Patients | Coautor: Candelaria M., Cetina G., Fernandez O., Aguilar I., et al. | 2022 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | WoS-id: 000897948100446
Scopus-id: 2-s2.0-85138584996
| 0 | 0 |
| 7 | Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma | 1ᵉʳ autor: Candelaria, Myrna, Duenas-Gonzalez, Alfonso | 2021 | Therapeutic Advances in Hematology | WoS-id: 000617275600001
| 20 | 0 |
| 8 | Central Nervous System International Prognostic Index Impacts Overall Survival in Diffuse Large B-cell Lymphoma Treated with R-Chop in a third Level Cancer Center from Mexico: A Survey of 642 Patients | Coautor: Candelaria-Hernández M., Solís-Armenta R., Cacho-Díaz B., Gutiérrez-Hernández O. | 2021 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000681314700005
Scopus-id: 2-s2.0-85112487962
| 2 | 2 |
| 9 | Primary myocardial diffuse large B cell lymphoma. Report of one case | Coautor y autor de correspondencia: Candelaria, Myrna, Rubalcava Lara, Luis F., Aviles-Salas, Alejandro | 2021 | REVISTA MEDICA DE CHILE | WoS-id: 000733663600016
Scopus-id: 2-s2.0-85122750746
| 1 | 2 |
| 10 | Regulation of miRNAs Expression by Mutant p53 Gain of Function in Cancer | Coautor: Candelaria, Myrna, Madrigal, Tzitzijanik, Hernandez-Monge, Jesus, Herrera, Luis A., et al. | 2021 | Frontiers In Cell And Developmental Biology | WoS-id: 000738310200001
Scopus-id: 2-s2.0-85121682942
| 11 | 11 |
| 11 | A COHORT STUDY OF THE PROGNOSTIC IMPACT OF EXON-16 EZH2 MUTATIONS IN A MEXICAN-MESTIZO POPULATION OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA | Coautor: Candelaria-Hernandez, Myrna, Oñate-Ocaña L.F., Ponce-Martinez, Mayra, Taja-Chayeb, Lucia, et al. | 2021 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000755116800004
Scopus-id: 2-s2.0-85121957733
| 2 | 3 |
| 12 | Real-world data on adult t-cell leukemia/lymphoma in latin america: A study from the grupo de estudio latinoamericano de linfoproliferativos | Coautor: Candelaria M., Malpica L., Enriquez D.J., Castro D.A., et al. | 2021 | Jco Global Oncology | WoS-id: 000757079500009
Scopus-id: 2-s2.0-85111878220
| 21 | 23 |
| 13 | Transitory response of a myelodysplastic syndrome with deletion of chromosome 5q to thalidomide. Report of one case | Coautor: Candelaria M., Palacios-Campos A., Gutierrez O., Fabian-Morales E., et al. | 2020 | REVISTA MEDICA DE CHILE | WoS-id: 000604270300017
Scopus-id: 2-s2.0-85098584959
| 1 | 1 |
| 14 | Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study | 1ᵉʳ autor: Candelaria M., González D.E., Delamain M.T., Bär D.O., et al. | 2019 | LEUKEMIA & LYMPHOMA | WoS-id: 000485520500001
Scopus-id: 2-s2.0-85068603224
| 27 | 25 |
| 15 | CLINICAL CHARACTERISTICS OF PRIMARY EXTRANODAL VERSUS NODAL DIFFUSE LARGE B-CELL LYMPHOMA: A RETROSPECTIVE COHORT STUDY IN A CANCER CENTER | 1ᵉʳ autor: Candelaria M., Oñate-Ocaña L.F., Corona-Herrera J., Barrera-Carmona C., et al. | 2019 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000505685000007
Scopus-id: 2-s2.0-85073118743
| 5 | 5 |
| 16 | Assessment of Different Biological Variables (Serum Albumin, beta-2-icroglobulin, Lymphocyte/Monocyte ratio, Neutrophil/Lymphocyte ratio, Platelet/Lymphocyte ratio) in a Retrospective Cohort of 525 Diffuse Large B-Cell Lymphomas As Predictor Factor(s) for Overall Survival | Coautor: Candelaria, Myrna, Villela, Luis, Ramirez-Ibarguen, Ana, Beltran, Brady E., et al. | 2019 | Blood | WoS-id: 000577160402165
| 0 | 0 |
| 17 | Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83?, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach | 1ᵉʳ autor: Candelaria M., Gonzalez D., Fernández Gómez F.J., Paravisini A., et al. | 2018 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000426060100009
Scopus-id: 2-s2.0-85040860793
| 32 | 32 |
| 18 | A prognostic score for survival in patients older than 65 years with diffuse large B-Cell Lymphoma | 1ᵉʳ autor: Candelaria M., Reynoso-Noverón N., Ponce M., Castillo-Llanos R., et al. | 2018 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000430528600006
Scopus-id: 2-s2.0-85046630653
| 3 | 3 |
| 19 | Metabolic tumor volume changes assessed by interval (18)fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma | Coautor: Candelaria M., Oñate-Ocaña L.F., Cortés V., Castillo-Llanos R., et al. | 2018 | ONCOLOGY LETTERS | WoS-id: 000444763100006
Scopus-id: 2-s2.0-85049470577
| 13 | 12 |
| 20 | Platelet count is associated with outcome in cancer patients with stroke | Coautor: Candelaria M., Cacho-Díaz B., Spínola-Maroño H., Mendoza-Olivas L.G. | 2018 | JOURNAL OF NEURO-ONCOLOGY | WoS-id: 000451635500009
Scopus-id: 2-s2.0-85052663490
| 9 | 9 |
| 21 | Late-Onset Cytopenias and Therapy Related Myeloid Malignancies in a Cohort of Patients with Lymphoproliferative Disorders at Instituto Nacional De Cancerologia- Mexico | Coautor: Candelaria, Myrna, Palacios Campos, Adriana, Corona Herrera, Judith Monserrat, Fabian Morales, Eunice | 2018 | Blood | WoS-id: 000454842806361
| 0 | 0 |
| 22 | Transformación leucémica en paciente con linfoma folicular e hiperleucocitosis al diagnóstico | Coautor: Candelaria M., Canales S.B., Avilés-Salas A., Hernández O.G., et al. | 2018 | Revista Cubana de Hematologia, Inmunologia y Hemoterapia | Scopus-id: 2-s2.0-85056587247
| 0 | 0 |
| 23 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study | Coautor: Candelaria, M., Espinoza-Zamora, J.R., Labardini-Méndez, J., Sosa-Espinoza, A., et al. | 2017 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | WoS-id: 000399605800008
Scopus-id: 2-s2.0-85012904936
| 21 | 22 |
| 24 | Large B-cell lymphoma coexisting with Castleman's disease. Report of one case | 2ᵒ autor: Candelaria, Myrna, Aviles-Salas, Alejandro, Sevilla-Lizcano, Diana Brisa, Burgos, Sebastian | 2017 | REVISTA MEDICA DE CHILE | WoS-id: 000411759700016
Scopus-id: 2-s2.0-85032002787
| 2 | 2 |
| 25 | Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP?) as epigenetic treatment for myelodysplastic syndrome (MDS) | 1ᵉʳ autor: Candelaria, Myrna, Burgos, Sebastian, Ponce, Mayra, Espinoza, Ramiro, et al. | 2017 | ANNALS OF HEMATOLOGY | WoS-id: 000413247400005
Scopus-id: 2-s2.0-85027859318
| 17 | 17 |
| 26 | Blastic plasmacytoid dendritic cell neoplasm. Report of three cases | 2ᵒ autor: Candelaria, Myrna, Aviles-Salas, Alejandro, Ponce, Mayra, Canavera-Constantino, Abraham, et al. | 2017 | REVISTA MEDICA DE CHILE | WoS-id: 000416126800017
Scopus-id: 2-s2.0-85037719880
| 0 | 0 |
| 27 | Advances in the diagnosis and control of lymphomas | 1ᵉʳ autor y autor de correspondencia: Candelaria, M. | 2016 | SALUD PUBLICA DE MEXICO | WoS-id: 000372689500024
Scopus-id: 2-s2.0-84969981393
| 4 | 4 |
| 28 | G80A SINGLE NUCLEOTIDE POLYMORPHISM IN REDUCED FOLATE CARRIER-1 GENE IN A MEXICAN POPULATION AND ITS IMPACT ON SURVIVAL IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA | 1ᵉʳ autor: Candelaria, Myrna, Ojeda, Juan, Gutierrez-Hernandez, Olga, Taja-Chayeb, Lucia, et al. | 2016 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000379988100008
Scopus-id: 2-s2.0-85021859466
| 3 | 4 |
| 29 | Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico | Coautor: Candelaria, Myrna, Nolasco-Medina, Diana, Reynoso-Noveron, Nancy, Mohar-Betancourt, Alejandro, et al. | 2016 | BIOMED RESEARCH INTERNATIONAL | WoS-id: 000380336500001
Scopus-id: 2-s2.0-84979984672
| 11 | 9 |
| 30 | Imatinib Intolerance Is Associated With Blastic Phase Development in Philadelphia Chromosome?Positive Chronic Myeloid Leukemia | Coautor: Candelaria-Hernández, M., Ángeles-Velázquez, J.L., Hurtado-Monroy, R., Vargas-Viveros, P., et al. | 2016 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | WoS-id: 000381960600016
Scopus-id: 2-s2.0-84992055591
| 3 | 4 |
| 31 | Initial surgical management of squamous carcinoma of the vulva | Coautor: Candelaria-Hernández, M., Salazar-Báez, I., Salazar-Campos, J.E., López-Arias, A., et al. | 2016 | GACETA MEDICA DE MEXICO | WoS-id: 000384933800003
Scopus-id: 2-s2.0-84982947709
| 0 | 3 |
| 32 | Expression Levels of Human Equilibrative Nucleoside Transporter 1 and Deoxycytidine Kinase Enzyme as Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with Cytarabine | 1ᵉʳ autor: Candelaria M., Corrales-Alfaro C., Gutiérrez-Hernández O., Díaz-Chavez J., et al. | 2016 | Chemotherapy | WoS-id: 000386891600005
Scopus-id: 2-s2.0-84973861029
| 9 | 9 |
| 33 | Therapy-related myelodysplastic syndrome | 1ᵉʳ autor: Candelaria M., DuenasGonzalez, A | 2015 | EXPERT OPINION ON DRUG SAFETY | WoS-id: 000353209600005
Scopus-id: 2-s2.0-84928319854
| 9 | 13 |
| 34 | Impact of Anthracycline Dose in Elderly Patients with Difusse Large B Cell Lymphoma (DLBCL) at the Instituto Nacional De Cancerologia Mexico | Coautor: Candelaria, M, Nolasco, D, Alejandro, M, ReynosoNoveron, N, et al. | 2015 | Blood | WoS-id: 000368021804042
| 0 | 0 |
| 35 | Science and confidence: The need to be clear - Response [Ciencia y confianza: La necesidad de ser claros - Respuesta] | 1ᵉʳ autor y autor de correspondencia: Candelaria-Hernández M. | 2014 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000339933100014
Scopus-id: 2-s2.0-84901033459
| 0 | 0 |
| 36 | Impact of a federal program on response rate & survival, in a cohort of patients with diffiise large B-cell lymphoma. Analysis in a single national reference institution in México | 1ᵉʳ autor: Candelaria M., Labardini-Mendez J., Ramirez-Lbarguen A.F., Avilés-Salas A., et al. | 2014 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000352520500004
Scopus-id: 2-s2.0-84938053593
| 3 | 2 |
| 37 | Pemphigus and obliterating bronchiolitis: Multiorgan autoimmune paraneoplastic syndrome in a patient with follicular lymphoma [Pénfigo y bronquiolitis obliterante como manifestaciones de síndrome paraneoplásico autoinmune en un paciente c | 1ᵉʳ autor: Candelaria M., De La Torre A., Vega M.T., Ramirez A., et al. | 2014 | Piel | Scopus-id: 2-s2.0-84908452086
| 0 | 0 |
| 38 | Guias nacionales de diagnóstico y tratamiento de linfoma no Hodgkin | 1ᵉʳ autor: Candelaria M., Cervera-Ceballos E., Meneses-García A., Avilés-Salas A., et al. | 2013 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000339933000001
Scopus-id: 2-s2.0-84887475828
| 4 | 4 |
| 39 | National guidelines of non-Hodgkin lymphoma [Guías Nacionales de Linfona no-Hodgkin] | 1ᵉʳ autor y autor de correspondencia: Candelaria-Hernández M.G. | 2013 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000339933900012
Scopus-id: 2-s2.0-84896797850
| 0 | 0 |
| 40 | Improvement in the quality of life and symptomatic response in patients with primary myelofibrosis, postpolycythemia vera myelofibrosis and essential postthrombocythemia myelofibrosis treated with the inhibitor of JAK-1 and JAK-2 ruxolitinib | Coautor y autor de correspondencia: Candelaria-Hernández M.G., Vargas-Viveros P., Hurtado-Monroy R. | 2013 | Medicina Interna De México | Scopus-id: 2-s2.0-84883274447
| 0 | 1 |
| 41 | Adenocarcinoma metastatic to the uterine cervix: A case series | Coautor: Candelaria M., Pérez-Montiel D., Serrano-Olvera A., Salazar L.C., et al. | 2012 | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH | WoS-id: 000300984300010
Scopus-id: 2-s2.0-84860866217
| 28 | 34 |
| 42 | Castleman's disease: Case report [Enfermedad de Castleman: Reporte de un caso] | Coautor: Candelaria M., Bourlon R., Gallegos C., Zárate-Osorno A., et al. | 2012 | Medicina Interna De México | Scopus-id: 2-s2.0-84858181557
| 0 | 0 |
| 43 | Gallbladder disease as a manifestation of Weil's disease. Report of a case where a resident of Mexico City [Colecistopatía como manifestación de enfermedad de Weil. Reporte de un caso en un habitante de la Ciudad de México] | Coautor: Hernández M.G.C., Pluma V.H.C., López C.A.V., Urquiza R.V., et al. | 2012 | Medicina Interna De México | Scopus-id: 2-s2.0-84861537965
| 0 | 0 |
| 44 | Tonsillar and rectal infiltration as the initial manifestation in AML M5 [Infiltración amigdalina y rectal como manifestación inicial en leucemia mieloide aguda M5] | 2ᵒ autor: Hernández M.G.C., Cuéllar R.A.B., Villanueva J.A.V., Paez I.P., et al. | 2011 | Medicina Interna De México | Scopus-id: 2-s2.0-80755148687
| 0 | 0 |
| 45 | Epigenetic changes in nucleoside transporter hENT1 and dCK, as mechanism for gemcitabine-aquired resistance in cervical cancer cell lines. | 1ᵉʳ autor: Candelaria, M, de la Cruz-Hernandez, E, Gonzalez-Fierro, A, Perez-Cardenas, E, et al. | 2010 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000208852000484
| 0 | 0 |
| 46 | Lack in efficacy for imatinib mesylate as second-line treatment of recurrent or metastatic cervical cancer expressing platelet-derived growth factor receptor a | 1ᵉʳ autor: Candelaria M., Arias-Bonfill D., Chávez-Blanco A., Chanona J., et al. | 2009 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000272898400033
Scopus-id: 2-s2.0-77649193788
| 25 | 32 |
| 47 | Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors | 2ᵒ autor: Candelaria M., Duenas-Gonzalez A., Perez-Plascencia C., Perez-Cardenas E., et al. | 2008 | CANCER TREAT REV | WoS-id: 000256326000002
Scopus-id: 2-s2.0-42649109021
| 294 | 310 |
| 48 | Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer | Coautor: Candelaria, M, Cetina, L, Garcia-Arias, A, Uribe, MD, et al. | 2008 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000260301200010
Scopus-id: 2-s2.0-56749122221
| 28 | 33 |
| 49 | The prince and the pauper. A tale of anticancer targeted agents | Coautor: Candelaria M., Duenas-Gonzalez, A, García-López P., Herrera L.A., et al. | 2008 | MOLECULAR CANCER | WoS-id: 000262378700001
Scopus-id: 2-s2.0-58249116704
| 73 | 78 |
| 50 | Clinical implications of gemcitabine in the treatment of cervical cancer | 1ᵉʳ autor: Candelaria M., Cetina L., de la Garza J., Dueñas-Gonzálz A. | 2007 | EJC SUPPL | WoS-id: 000244377300007
Scopus-id: 2-s2.0-34248519436
| 7 | 7 |
| 51 | The prognostic significance of leukocytosis in cervical cancer | Coautor: Candelaria M., Garcia-Arias A., Cetina L., Robles E., et al. | 2007 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000244885300022
Scopus-id: 2-s2.0-33947246972
| 24 | 30 |
| 52 | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors | 1ᵉʳ autor: Candelaria M., Gallardo-Rincón D., Arce C., Cetina L., et al. | 2007 | ANNALS OF ONCOLOGY | WoS-id: 000250437200016
Scopus-id: 2-s2.0-34548395116
| 208 | 231 |
| 53 | Tamoxifen-associated vasculitis in a breast cancer patient | 1ᵉʳ autor: Candelaria M., Hurtado-Monroy R., Vargas-Viveros P., Carrillo-Muñnoz S., et al. | 2007 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-33846971221
| 0 | 9 |
| 54 | Radiosensitizers in cervical cancer. Cisplatin and beyond | 1ᵉʳ autor: Candelaria M., Garcia-Arias A., Cetina L., Dueñas-Gonzalez A. | 2006 | RADIAT ONCOL | WoS-id: 000204479500015
Scopus-id: 2-s2.0-33845416730
| 74 | 83 |
| 55 | A proof-of-principle study of epigenetics therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer | Coautor: Candelaria M., Arce C., Pérez C., González-Fierro A., et al. | 2006 | PLOS ONE | WoS-id: 000207443600097
Scopus-id: 2-s2.0-33847786883
| 121 | 131 |
| 56 | Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines | Coautor: Candelaria M., Chavez-Blanco A., Perez-Plasencia C., Perez-Cardenas E., et al. | 2006 | CANCER CELL INTERNATIONAL | WoS-id: 000208405000002
Scopus-id: 2-s2.0-33645071947
| 108 | 124 |
| 57 | Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer | Coautor: Candelaria M., Taja-Chayeb L., Chavez-Blanco A., Martínez-Tlahuel J., et al. | 2006 | CANCER CELL INTERNATIONAL | WoS-id: 000208405000022
Scopus-id: 2-s2.0-33750203160
| 33 | 33 |
| 58 | Hydralazine target: From blood vessels to the epigenome | Coautor: Candelaria M., Arce C., Segura-Pacheco B., Perez-Cardenas E., et al. | 2006 | JOURNAL OF TRANSLATIONAL MEDICINE | WoS-id: 000236271700001
Scopus-id: 2-s2.0-33645210836
| 90 | 97 |
| 59 | Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer | Coautor: Candelaria M., Fernández-Sánchez M., Gamboa-Dominguez A., Uribe N., et al. | 2006 | MEDICAL ONCOLOGY | WoS-id: 000237371600003
Scopus-id: 2-s2.0-33646885250
| 29 | 32 |
| 60 | Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer | Coautor: Candelaria M., Serrano-Olvera A., Dueñas-González A., Gallardo-Rincón D., et al. | 2006 | CANCER TREAT REV | WoS-id: 000237684500003
Scopus-id: 2-s2.0-33645907542
| 115 | 123 |
| 61 | Prognostic significance of pathological response after neoadjuvant chemotherapy of chemoradiation for locally advanced cervical carcinoma | 1ᵉʳ autor: Candelaria M., Chanona-Vilchis J., Cetina L., Flores-Estrada D., et al. | 2006 | International Seminars in Surgical Oncology | Scopus-id: 2-s2.0-33644640421
| 0 | 32 |
| 62 | Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results | Coautor: Candelaria M., Cetina L., Rivera L., Hinojosa J., et al. | 2006 | BMC Womens Health | Scopus-id: 2-s2.0-33644663022
| 0 | 39 |
| 63 | Radiation-sparing managements for cervical cancer: A developing countries perspective | 1ᵉʳ autor: Candelaria M., Cetina L., Garcia-Arias A., Lopez-Graniel C., et al. | 2006 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-33845389613
| 0 | 10 |
| 64 | A clinical and biological overview of gastrointestinal stromal tumors | 1ᵉʳ autor: Candelaria M., De La Garza J., Duenas-Gonzalez A. | 2005 | MEDICAL ONCOLOGY | WoS-id: 000229104300001
Scopus-id: 2-s2.0-18444402504
| 13 | 14 |
| 65 | HER-2/neu expression as a predictive factor for response to anthracycline-based chemotherapy in a Mexican population of locally advanced breast cancer patients | Coautor: Candelaria M., Muñoz-Gonzalez D., Zeichner-Gancz I., Ramirez-Ugalde M.T., et al. | 2005 | MEDICAL ONCOLOGY | WoS-id: 000229104300004
Scopus-id: 2-s2.0-18444363377
| 3 | 4 |
| 66 | Anemia in cervical cancer patients: Implications for iron supplementation therapy | 1ᵉʳ autor: Candelaria M., Cetina L., Dueñas-González A. | 2005 | MEDICAL ONCOLOGY | WoS-id: 000230692900008
Scopus-id: 2-s2.0-22344449466
| 17 | 20 |
| 67 | Genetic determinants of cancer drug efficacy and toxicity: Practical considerations and perspectives | 1ᵉʳ autor: Candelaria M., Taja-Chayeb L., Arce-Salinas C., Vidal-Millan S., et al. | 2005 | ANTI-CANCER DRUGS | WoS-id: 000232563300004
Scopus-id: 2-s2.0-26244444364
| 21 | 24 |
| 68 | Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer | Coautor: Candelaria M., Lopez-Graniel C., Dolores R., Cetina L., et al. | 2005 | Bmc Cancer | WoS-id: 000232692700001
Scopus-id: 2-s2.0-26844481072
| 9 | 13 |
| 69 | Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation | 2ᵒ autor: Candelaria M., Taja-Chayeb L., Brom R., Trejo-Becerril C., et al. | 2005 | LUNG CANCER | WoS-id: 000232973600013
Scopus-id: 2-s2.0-26444607483
| 7 | 6 |
| 70 | Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study | Coautor: Candelaria M., Chavez-Blanco A., Segura-Pacheco B., Perez-Cardenas E., et al. | 2005 | MOLECULAR CANCER | WoS-id: 000239965000001
Scopus-id: 2-s2.0-26844505068
| 116 | 126 |
| 71 | Epigenetics of cervical cancer. An overview and therapeutic perspectives | Coautor: Candelaria M., Dueñas-González A., Lizano M., Cetina L., et al. | 2005 | MOLECULAR CANCER | WoS-id: 000239966700001
Scopus-id: 2-s2.0-27744492604
| 176 | 194 |
| 72 | Gestational trophoblastic disease. Experience at National Institute of Cancerology [Enfermedad trofoblástica gestacional. Experiencia en el Instituto Nacional de Cancerología] | Coautor: Candelaria M., Lara M F., Alvarado M A., Arce Salinas C. | 2005 | Ginecología Y Obstetricia De México | Scopus-id: 2-s2.0-33644877707
| 0 | 9 |
| 73 | HER2 expression in cervical cancer as a potential therapeutic target | Coautor: Candelaria M., Chavez-Blanco A., Perez-Sanchez V., Gonzalez-Fierro A., et al. | 2004 | Bmc Cancer | WoS-id: 000224043200001
Scopus-id: 2-s2.0-13144302944
| 59 | 65 |
| 74 | Chemoradiation with gemcitabine for cervical cancer in patients with renal failure | Coautor: Candelaria M., Cetina L., Rivera L., De La Garza J., et al. | 2004 | ANTI-CANCER DRUGS | WoS-id: 000224111400004
Scopus-id: 2-s2.0-4644318305
| 14 | 22 |
| 75 | Ocular metastases from breast carcinoma | Coautor: Candelaria-Hernández M., Mejía-Novelo A., Alvarado-Miranda A., Morales-Vázquez F., et al. | 2004 | MEDICAL ONCOLOGY | WoS-id: 000224684900002
Scopus-id: 2-s2.0-7944233091
| 12 | 12 |
| 76 | Gastrointestinal pneumatosis after docetaxel chemotherapy | 1ᵉʳ autor: Candelaria M., Bourlon-Cuellar R., Zubieta J.L.G.-L., Noel-Ettiene L.M., et al. | 2002 | JOURNAL OF CLINICAL GASTROENTEROLOGY | WoS-id: 000174716100012
Scopus-id: 2-s2.0-0036202568
| 18 | 24 |
| 77 | Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours | 2ᵒ autor: Candelaria M., Hartmann J.T., Kuczyk M.A., Schmoll H.-J., et al. | 1997 | EUROPEAN JOURNAL OF CANCER | WoS-id: A1997XF60500018
Scopus-id: 2-s2.0-0030790346
| 75 | 85 |
| 78 | Postchemotherapy resections of residual masses from metastatic non- seminomatous testicular germ cell tumors | Coautor: Candelaria M., Hartmann J.T., Schmoll H.-J., Kuczyk M.A., et al. | 1997 | ANNALS OF ONCOLOGY | WoS-id: A1997XN79200013
Scopus-id: 2-s2.0-0030871931
| 68 | 90 |
| 79 | rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia | 2ᵒ autor: Candelaria M., Hurtado R., Vargas F., Majluf A., et al. | 1995 | Stem Cells | WoS-id: A1995QN61400003
Scopus-id: 2-s2.0-0028958745
| 7 | 6 |
| 80 | Non-neoplastic polyps of the colon [Pólipos no neoplásicos del colon.] | 2ᵒ autor y autor de correspondencia: Candelaria Hernández M.G., Gallo Reynoso S. | 1993 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0027345245
| 0 | 1 |
| 81 | Neoplastic polyps of the colon [Pólipos neoplásicos del colon.] | 2ᵒ autor y autor de correspondencia: Candelaria Hernández M.G., Gallo Reynoso S. | 1992 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0026477011
| 0 | 1 |
| 82 | Emergency endoscopic sclerosis in esophageal varices [Esclerosis endoscópica de urgencia en várices esofágicas.] | 2ᵒ autor: Candelaria M., Gallo Reynoso S., Elizondo Rivera J. | 1991 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-17544397062
| 0 | 0 |
| 83 | Elective endoscopic sclerotherapy in esophageal varices [Esclerosis endoscópica electiva de várices esofágicas.] | 2ᵒ autor: Candelaria M., Elizondo J., Gallo S. | 1990 | REVISTA DE GASTROENTEROLOGIA DE MEXICO | Scopus-id: 2-s2.0-0025459135
| 0 | 1 |
| 84 | A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL) | Coautor: Candelaria M., Beltrán B.E., Villela L., Torres M.A., et al. | | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | WoS-id: 000585113900017
Scopus-id: 2-s2.0-85085950627
| 4 | 5 |
ID's SCOPUS 